Clinical Trials in New York

Showing 10701-10720 of 22,668 trials

Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease

NCT02378701

The goal of this research study is to test a quality-of-life questionnaire called QUALMS-1 in patients with MDS. This is an investigational study. Up to 240 participants will be enrolled in this multicenter study. Up to 175 will take part at MD Anderson.

Leukemia

M.D. Anderson Cancer Center102 participantsStarted Feb 2015

Tampa, Florida, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +3 more locations

WITHDRAWNPhase 2< 1 mile

Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients

NCT04001413

Combination immune checkpoint inhibitor and DNA vaccine will result in clearance of HPV DNA biomarkers (oral and/or plasma) for patients with persistent HPV-16 E6/E7 DNA (HPV biomarker) after treatment with curative intent.

HPV Positive Oropharyngeal Squamous Cell CarcinomaOropharynx CancerHPV-Related Carcinoma

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsStarted Sep 2019

Baltimore, Maryland, United States • New York, New York, United States • New York, New York, United States +1 more locations

Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease

Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients

Find Trials by Condition in New York

Intratumoral Microdosing of TAK-981 in Head and Neck Cancer

Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

Impact of Telehealth on Engagement in Psychotherapy and/or Medication Treatment

Evolocumab In Advanced Chronic Kidney Disease Trial

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial

A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia

Remote Wheelchair Skills Training Efficacy

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis

ET-01 in Subjects With Lateral Canthal Lines, LCL-209

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic Hepatitis

Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients